SC
ABBV icon

StellarOne Corp’s AbbVie ABBV Stock Holding History

StellarOne Corp’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.11M Sell
24,778
-7,387
-23% -$327K 0.82% 55
2013
Q2 		$1.33M Buy
+32,165
New +$1.41M 1.02% 50

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

StellarOne Corp's ABBV Position: Q3 2013 in Review

StellarOne Corp reduced its AbbVie (ABBV) stake by 23% in Q3 2013, selling an estimated $327K and leaving 24,778 shares worth $1.11M. The position accounts for 0.82% of the portfolio, ranked #55.

StellarOne Corp first reported a position in ABBV in Q2 2013 and has held it in 2 quarters since. The position peaked at $1.33M in Q2 2013. 1,296 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

  • StellarOne Corp held 24,778 shares of AbbVie worth $1.11M as of Q3 2013.
  • StellarOne Corp sold 7,387 AbbVie shares in Q3 2013, an estimated $327K.
  • AbbVie made up 0.82% of StellarOne Corp's portfolio in Q3 2013, its #55 holding.
  • StellarOne Corp first reported a position in AbbVie in Q2 2013 and has held it in 2 quarters since.
  • StellarOne Corp's AbbVie position peaked at $1.33M in Q2 2013.
  • 1,296 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on StellarOne Corp's 13F filing for Q3 2013, filed 12 Nov 2013.